The study was conducted at Chest Department, Clinical Pathology Department, and Respiratory ICU Unit at Zagazig University Hospitals. A total of 85 patients were included in this study (20 healthy controls, 20 patients with chronic bronchitis, 20 asthmatic patients, 20 patients with chronic obstructive pulmonary disease, and five patients with myopathy). Serial measurements of forced expiratory volume in 1 s % predicted were done. Induced sputum by lung flute and hypertonic saline was obtained. Sputum and saliva samples were processed and examined.
Introduction
Induction of sputum by noninvasive methods from lower respiratory tract has evolved as an important tool for diagnosis and management of different respiratory diseases. Aim of the study To assess the efficacy and safety of lung flute compared with the standard methods.
A low-frequency acoustic wave when generated in the mouth has the potential to reach retrograde into the lower respiratory tract, vibrate tracheobronchial secretions, and increase mucociliary clearance, thereby helping in induction of sputum [1] .
The lung flute is a new small self-powered audio device that has been classified by the Food and Drug Administration to the family of Oscillatory Positive Expiratory Pressure devices, which includes the Flutter and the Acapella [2] . The lung flute is a small device that generates audio waves (18) (19) (20) (21) (22) . With vigorous exhalation, its output is 110-115 Db by using 2.5 cmH 2 O of pressure [3] .
Inhalation of nebulized hypertonic saline is effective in inducing sputum and was considered the standard method [4] . Limitations of induction with hypertonic saline have prevented its clinical widespread application [5] . These limitations included the substantial occurrence of bronchoconstriction with proinflammatory effect on the airways, and it is a long-time procedure that needs specialized training and equipment [6] .
Analysis of samples of lower respiratory tract secretions is useful in clinical management as well as research in several respiratory disorders [7] . Cellular, biochemical, and immunological analyses of sputum samples have become an important research tool in different diseases, especially asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis [8] .
Sputum induction promotes lung expansion, yet preventing both microatelectasis and macroatelectasis, through deep breathing, which should be held for several seconds and thus promoting collateral ventilation and helping in conscious control of ventilation [9] .
So the objectives of this study were to assess the efficacy, safety, and reliability of the lung flute for sputum induction and to establish its diagnostic and therapeutic applications.
Patients and methods

Study design
An observational prospective noninterventional clinical comparative study was conducted at Chest Department, Clinical Pathology Department, and Respiratory ICU Unit at Zagazig University Hospitals in the period from August 2016 to March 2018. The study protocol was approved by the institutional ethics committee, and written informed consent was obtained from all participants.
Patients
A total of 85 patients were included in this study [20 healthy controls, 20 patients with chronic bronchitis (CB), 20 asthmatic patients, 20 patients with COPD, and five patients with myopathy]. Thorough medical history was taken, and full clinical examination (general, throat, and chest examinations) was performed. Patients were enrolled in the study if they had retained secretions, congestion, and weak cough reflex and cannot produce adequate sputum samples by spontaneous expectoration.
Samples collections
Patients were instructed to stop eating, drinking (except water), or smoking for at least 30 min. A sample of saliva was collected from all patients before the sputuminduction procedure. Whole unstimulated saliva was collected by the passive drool technique.
The procedure of sputum induction was performed in one session for healthy controls by lung flute and two sessions 1 week apart for patients with respiratory diseases by lung flute and hypertonic saline. All study patients were evaluated for their baseline spirometric evaluation.
Patients were asked to take a deep inspiration followed by vigorous exhalations into lung flute up to 20 min in a way that makes the device fluttering with exhalation. After 5 min of completing exhalations, the patients were asked to cough and expectorate, and the material expectorated was collected over the next 10 min. One week later, reassessment of the throat and chest was done followed by induction with 30 ml of 3% hypertonic saline through nebulization with ultrasonic nebulizer, and during nebulization, the patients were instructed to stop every 5 min to clear mouth from saliva then cough and expectorate vigorously, and sputum specimen was collected.
Patients were asked and examined for possible adverse effects after each maneuver. They were followed up after 24 h and asked again about persistence of any adverse effect or appearance of new one.
Sample processing and analysis
The characteristics of samples were assessed as weight, pourability grade [10] , and macroscopic grading of purulence.
All saliva and sputum samples were processed within 120 min after collection; samples were treated in equal volume with dithiothreitol (DTT, Fluka, Switzerland) which was diluted with Dulbecco buffer (Sigma-Aldrich Corporation, Saint Louis, MO, USA) to reach a 0.1% concentration. The portions were mixed by vortex for 15 s and then placed in a shaking water bath at 37°C for 15 min to ensure complete homogenization. Samples were centrifuged at 1200g for 5 min to separate the supernatant, which was aspirated and stored at −80°C till biochemical analysis. The cell pellet was resuspended with saline, and the cellular components were assessed by hematoxylin-eosin staining with counting at least 400 cells per slide.
Biochemical assays of saliva and sputum samples were performed. Fibrinogen concentrations were quantified by using Human FG (Fibrinogen) ELISA Kit (MyBioSource, San Diego, California, USA) (catalog no.: MBS765734). Elastase was measured in samples of saliva and sputum with Human PMN Elastase ELISA (BioVendor Laboratory Medicine, Brno, Czech Republic) (catalog no.: RM191021100). Assays were performed according to the manufacturer's directions.
Statistical analysis
Shapiro-Wilk test was used to check the data normality. Continuous variables are presented as mean±SD. Categorical variables are presented as an absolute number and percentage. Student t test and χ 2 test were used. Statistical analysis was carried out with SPSS software (SPSS Chicago, IL, USA). Significance was considered at P value less than 0.05.
Results
The study included 85 patients, and their demographic and clinical characteristics were presented in ( Table 1) .
All healthy participants, patients with asthma, and patients with myopathy were nonsmokers, whereas all patients with COPD were current smokers, with mean pack-years of 47.8±4.4, and 19 of 20 patients in the CB group were current smokers with mean packyears of 17.7±4.3. Among the studied patients, there were 28 patients with comorbidities in the form of 10 hypertensive asthmatic patients, eight patients with hypertensive COPD, six diabetic patients with COPD, and four patients with myopathy with cardiac problems.
Samples obtained by lung flute are significantly larger in weight than salivary samples in healthy participants. There was a highly statistical significant difference in percent of macrophages, neutrophils, eosinophils, and alveolar epithelial cells in lung flute-induced sputum samples versus saliva. However, saliva was higher in squamous cells and lymphocytes. Fibrinogen level was significantly higher in sputum samples in contrary to saliva (P<0.0001), whereas the elastase level in sputum samples in comparison with saliva was insignificant (P=0.39) ( Table 2 ).
The weight of sputum samples obtained by lung flute was higher in all studied diseased groups in comparison with salivary samples. Cellular elements were statically higher in lung flute-induced samples versus saliva except for lymphocytes and eosinophils in myopathy group (P=0.053 and 0.17, respectively). Regarding fibrinogen level, there is statistically significant difference between lung flute-induced sputum samples and saliva. Elastase level also was significantly higher in all studied diseased groups in sputum samples versus saliva ( Table 2 ).
The weight of sputum is significantly higher in amount in all studied patients in induced sputum by lung flute relative to hypertonic saline-induced sputum (P<0.0001). There is no significant statistical difference between sputum induced by lung flute and that induced by hypertonic saline regarding pourability grading. Squamous cells are significantly higher when using hypertonic saline for sputum induction in CB, asthmatics, and COPD groups (P<0.0001, <0.0001, and 0.012, respectively). Macrophages, neutrophils, lymphocytes, and eosinophils percentage are comparable by both methods. Alveolar (epithelial) cell percent is significantly higher in CB and COPD group in those with lung flute-induced sputum (P=0.003 and P<0.0001, respectively). There is no statistically significant difference between fibrinogen and elastase levels in all studied patients when comparing sputum induced by lung flute and that induced by hypertonic saline (Table 3) .
Some reported complications of sputum induction were reported in the form of nausea, vomiting, and bronchospasm. Three reported cases of nausea, four reported cases of vomiting with lung flute, whereas 16 reported nausea cases, 43 cases experienced vomiting, and three cases developed bronchospasm after using hypertonic saline for sputum induction as shown in (Table 3 ). There was significant improvement in mean forced expiratory volume in 1 s % predicted after usage of lung flute (Table 4 ) and also a great improvement in exercise performance and cough reflex.
Discussion
Inhalation of hyperosmolar agents, such as nebulized hypertonic saline, induces sputum by increasing mucociliary activity and increasing the transportability of mucus [11] . Several limitations have prevented its widespread clinical application including bronchoconstriction with potential proinflammatory effect on the airways, needs training, needs specialized equipment, and consumes time [12] .
So the aim of this study is to establish the effectiveness of lung flute in sputum induction. Lung flute is a small self-powered audio, reusable, plastic device that is noninvasive, easy to use, and drug free. It uses sound waves to break up mucus in the lungs, as the generated sound waves travel down the tracheobronchial tree and vibrate tracheobronchial secretions, thus enhancing the mucociliary clearance, especially of lower respiratory tract [13] .
It was mandatory to confirm sputum samples obtained by lung flute and differentiate it from saliva. The weight of samples obtained by lung flute was much higher than salivary samples. Regarding cellular components, lung flute-induced sputum samples showed significant numbers of macrophages and alveolar cells whereas saliva samples were higher in squamous cells. These findings proved that the sputum samples are of lower respiratory tract origin with no saliva contamination. This agrees with the findings of Su et al. [14] .
Fibrinogen levels were significantly higher in sputum samples in all study patients. Elastase levels were significantly higher in patients with respiratory disease in lung flute-induced sputum samples than saliva samples. However, a clinical study conducted on patients with CB showed that sputum fibrinogen and elastase were very similar to the levels in the corresponding saliva samples [15] . Samples obtained by lung flute were not contaminated with saliva as sputum samples had significantly greater amounts of fibrinogen, more non-squamous cells and macroscopically were more purulent than saliva.
For any new method, it was mandatory to compare it with the reliable standard method like hypertonic saline. Lung flute-obtained samples are comparable to those obtained by hypertonic saline regarding pourability grade, fibrinogen, and elastase levels. However, weight of samples obtained by lung flute was higher than those obtained by hypertonic saline. Cellular components in lung flute samples had significantly larger number of alveolar cells, whereas a higher percentage of squamous cells were detected in induced sputum by hypertonic saline. Therefore, sputum induced by the lung flute displayed comparable features or even better when compared with the standard method.
An observed major advantage of lung flute was the lower incidence of reported complications in comparison with hypertonic saline such as nausea, vomiting, and bronchospasm. This is in agreement with Rodriguez et al. [16] and Sakashita et al. [17] who reported that lung flute showed significantly fewer adverse events. However, Sakasihta et al. [18] showed that the frequency of adverse events was not different in lung flute or hypertonic saline.Significant improvements in chronic obstructive symptoms, exercise capacity, reduced probability of exacerbation, better response to treatment together, and significant increase in mean forced expiratory volume in 1 s were noticed during follow-up of the patients. This confirms the previous findings [2] .
Our study found good diagnostic and therapeutic value of lung flute in patients with different respiratory diseases. This result confirms the previous result of Anjuman et al. [19] and Ashwini and Medha [20] .
Conclusion
Lung flute can be considered a safe, effective, and convenient method to obtain samples of lower respiratory tract secretions noninvasively. Lung flute can be applied in research ,in diagnosis and in treatment of a wide variety of respiratory diseases.
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